|
1
|
Shepard TH, Landing BH and Mason DG:
Familial Addison's disease; case reports of two sisters with
corticoid deficiency unassociated with hypoaldosteronism. AMA J Dis
Child. 97:154–162. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark AJ, McLoughlin L and Grossman A:
Familial glucocorticoid deficiency associated with point mutation
in the adrenocorticotropin receptor. Lancet. 341:461–462. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Metherell LA, Chapple JP, Cooray S, David
A, Becker C, Rüschendorf F, Naville D, Begeot M, Khoo B, Nürnberg
P, et al: Mutations in MRAP, encoding a new interacting partner of
the ACTH receptor, cause familial glucocorticoid deficiency type 2.
Nat Genet. 37:166–170. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meimaridou E, Kowalczyk J, Guasti L,
Hughes CR, Wagner F, Frommolt P, Nürnberg P, Mann NP, Banerjee R,
Saka HN, et al: Mutations in NNT encoding nicotinamide nucleotide
transhydrogenase cause familial glucocorticoid deficiency. Nat
Genet. 44:740–742. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hughes CR, Guasti L, Meimaridou E, Chuang
CH, Schimenti JC, King PJ, Costigan C, Clark AJ and Metherell LA:
MCM4 mutation causes adrenal failure, short stature and natural
killer cell deficiency in humans. J Clin Invest. 122:814–820. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prasad R, Chan LF, Hughes CR, Kaski JP,
Kowalczyk JC, Savage MO, Peters CJ, Nathwani N, Clark AJ, Storr HL
and Metherell LA: Thioredoxin Reductase 2 (TXNRD2) mutation
associated with familial glucocorticoid deficiency (FGD). J Clin
Endocrinol Metab. 99:E1556–E1563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Metherell LA, Naville D, Halaby G, Begeot
M, Huebner A, Nürnberg G, Nürnberg P, Green J, Tomlinson JW, Krone
NP, et al: Nonclassic lipoid congenital adrenal hyperplasia
masquerading as familial glucocorticoid deficiency. J Clin
Endocrinol Metab. 94:3865–3871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Flück CE, Tajima T, Pandey AV, Arlt W,
Okuhara K, Verge CF, Jabs EW, Mendonça BB, Fujieda K and Miller WL:
Mutant P450 oxidoreductase causes disordered steroidogenesis with
and without Antley-Bixler syndrome. Nat Genet. 36:228–230. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bose HS, Pescovitz OH and Miller WL:
Spontaneous feminization in a 46, XX female patient with congenital
lipoid adrenal hyperplasia due to a homozygous frameshift mutation
in the steroidogenic acute regulatory protein. J Clin Endocrinol
Metab. 82:1511–1515. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujieda K, Tajima T, Nakae J, Sageshima S,
Tachibana K, Suwa S, Sugawara T and Strauss JF III: Spontaneous
puberty in 46,XX subjects with congenital lipoid adrenal
hyperplasia. Ovarian steroidogenesis is spared to some extent
despite inactivating mutations in the steroidogenic acute
regulatory protein (StAR) gene. J Clin Invest. 99:1265–1271. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clark BJ, Wells J, King SR and Stocco DM:
The purification, cloning, and expression of a novel luteinizing
hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor
cells. Characterization of the steroidogenic acute regulatory
protein (StAR). J Biol Chem. 269:28314–28322. 1994.PubMed/NCBI
|
|
12
|
King SR, Ronen-Fuhrmann T, Timberg R,
Clark BJ, Orly J and Stocco DM: Steroid production after in vitro
transcription, translation, and mitochondrial processing of protein
products of complementary deoxyribonucleic acid for steroidogenic
acute regulatory protein. Endocrinology. 136:5165–5176. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsujishita Y and Hurley JH: Structure and
lipid transport mechanism of a StAR-related domain. Nat Struct
Biol. 7:408–414. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stocco DM and Clark BJ: Regulation of the
acute production of steroids in steroidogenic cells. Endocr Rev.
17:221–244. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhangoo A, Anhalt H, Ten S and King SR:
Phenotypic variations in lipoid congenital adrenal hyperplasia.
Pediatr Endocrinol Rev. 3:258–271. 2006.PubMed/NCBI
|
|
16
|
Baker BY, Lin L, Kim CJ, Raza J, Smith CP,
Miller WL and Achermann JC: Nonclassic congenital lipoid adrenal
hyperplasia: A new disorder of the steroidogenic acute regulatory
protein with very late presentation and normal male genitalia. J
Clin Endocrinol Metab. 91:4781–4785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flück CE, Pandey AV, Dick B, Camats N,
Fernández-Cancio M, Clemente M, Gussinyé M, Carrascosa A, Mullis PE
and Audi L: Characterization of novel StAR (steroidogenic acute
regulatory protein) mutations causing non-classic lipoid adrenal
hyperplasia. PLoS One. 6:e201782011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miller WL: Mitochondrial specificity of
the early steps in steroidogenesis. J Steroid Biochem Mol Biol.
55:607–616. 1995. View Article : Google Scholar : PubMed/NCBI
|
